Re: [Histonet] In House Labs in WSJ

2012-04-11 Thread Nicole Tatum
A screening >>> for most men since it is largely non-specific. That test is what leads >>> to the biopsies. Less screening = fewer biopsies = less revenue. >>> >>> Tim Morken >>> >>> >>> >>> -Original Message- >>> From:

Re: [Histonet] In House Labs in WSJ

2012-04-11 Thread Geoff McAuliffe
: histonet-boun...@lists.utsouthwestern.edu [mailto:histonet-boun...@lists.utsouthwestern.edu] On Behalf Of Daniel Schneider Sent: Tuesday, April 10, 2012 11:22 AM To: Histonet Subject: [Histonet] In House Labs in WSJ The Wall Street Journal served up a timely article for us. You'll see both sides o

Re: [Histonet] In House Labs in WSJ

2012-04-10 Thread Davide Costanzo
> biopsies. Less screening = fewer biopsies = less revenue. > > > > Tim Morken > > > > > > > > -Original Message- > > From: histonet-boun...@lists.utsouthwestern.edu [mailto: > histonet-boun...@lists.utsouthwestern.edu] On Behalf Of Daniel Schneider >

Re: [Histonet] In House Labs in WSJ

2012-04-10 Thread Kim Donadio
term. >> There is a recommendation out there to stop PSA screening for most men since >> it is largely non-specific. That test is what leads to the biopsies. Less >> screening = fewer biopsies = less revenue. >> >> Tim Morken >> >> >> >&g

RE: [Histonet] In House Labs in WSJ

2012-04-10 Thread Tony Henwood (SCHN)
histonet-boun...@lists.utsouthwestern.edu [mailto:histonet-boun...@lists.utsouthwestern.edu] On Behalf Of Morken, Timothy Sent: Wednesday, 11 April 2012 7:49 AM To: Kim Donadio Cc: Histonet Subject: RE: [Histonet] In House Labs in WSJ >From the New York Times: 1) U.S. Panel Says No to Prost

RE: [Histonet] In House Labs in WSJ

2012-04-10 Thread Morken, Timothy
to the biopsies. Less > screening = fewer biopsies = less revenue. > > Tim Morken > > > > -Original Message- > From: histonet-boun...@lists.utsouthwestern.edu > [mailto:histonet-boun...@lists.utsouthwestern.edu] On Behalf Of Daniel > Schneider > Sent: Tu

Re: [Histonet] In House Labs in WSJ

2012-04-10 Thread Kim Donadio
iopsies = less revenue. > > Tim Morken > > > > -Original Message- > From: histonet-boun...@lists.utsouthwestern.edu > [mailto:histonet-boun...@lists.utsouthwestern.edu] On Behalf Of Daniel > Schneider > Sent: Tuesday, April 10, 2012 11:22 AM > To: Histonet

RE: [Histonet] In House Labs in WSJ

2012-04-10 Thread Morken, Timothy
Sent: Tuesday, April 10, 2012 11:22 AM To: Histonet Subject: [Histonet] In House Labs in WSJ The Wall Street Journal served up a timely article for us. You'll see both sides of the argument below. One side is right. DLS HEALTH INDUSTRY April 9, 2012, 7:22 p.m. ET Prostate-Test Fees Challenge

[Histonet] In House Labs in WSJ

2012-04-10 Thread Daniel Schneider
The Wall Street Journal served up a timely article for us. You'll see both sides of the argument below. One side is right. DLS HEALTH INDUSTRY April 9, 2012, 7:22 p.m. ET Prostate-Test Fees Challenged By CHRISTOPHER WEAVER Doctors in urology groups that profit from tests for prostate cancer orde